Insider Trading: Eli Lilly and Co (LLY.N)
LLY.N on New York Stock Exchange
54.14USD
24 May 2013
54.14USD
24 May 2013
Price Change (% chg)
$-0.60 (-1.10%)
$-0.60 (-1.10%)
Prev Close
$54.74
$54.74
Open
$54.41
$54.41
Day's High
$54.45
$54.45
Day's Low
$53.89
$53.89
Volume
1,459,309
1,459,309
Avg. Vol
1,230,403
1,230,403
52-wk High
$58.40
$58.40
52-wk Low
$39.93
$39.93
HOOVER R DAVID
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 29 Nov 2012 | Buy | 3,083 | $47.03 | 22,486 |
| 29 Dec 2011 | Buy | 248 | $40.74 | 17,788 |
| 29 Nov 2011 | Buy | 319 | $36.34 | 18,383 |
| 29 Nov 2011 | Buy | 3,990 | $36.34 | 18,383 |
| 30 Oct 2011 | Buy | 226 | $37.97 | 14,074 |
| 29 Sep 2011 | Buy | 229 | $37.52 | 12,848 |
| 29 Sep 2011 | Buy | 229 | $37.81 | 13,848 |
| 30 Aug 2011 | Buy | 240 | $35.77 | 13,459 |
| 28 Jul 2011 | Buy | 226 | $38.05 | 13,219 |
| 29 Jun 2011 | Buy | 229 | $37.56 | 12,993 |
| 30 May 2011 | Buy | 219 | $39.15 | 12,615 |
Institutional Holders
| % Shares Owned: | 74.53% |
| # of Holders: | 1,274 |
| Total Shares Held: | 839,600,579 |
| 3 Mo. Net Change: | -11,822,421 |
| # New Positions: | 88 |
| # Closed Positions: | 75 |
| # Increased Positions: | 506 |
| # Reduced Positions: | 527 |
| # Net Buyers: | -21 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Ellen Marram |
66 | 2013 | Acting Chairperson of the Board, Lead Independent Director |
Derica Rice |
48 | 2013 | Acting Chief Executive Officer, Chief Financial Officer, Executive Vice President - Global Services |
Maria Crowe |
53 | 2012 | President - Manufacturing Operations |
Jan Lundberg |
59 | 2010 | Executive Vice President - Science and Technology, President - Lilly Research Laboratories |
Melissa Barnes |
44 | 2013 | Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer |
Michael Harrington |
50 | 2013 | Senior Vice President, General Counsel |
Stephen Fry |
47 | 2011 | Senior Vice President - Human Resources and Diversity |
Enrique Conterno |
46 | 2009 | Senior Vice President and President - Lilly Diabetes |
Susan Mahony |
48 | 2011 | Senior Vice President and President - Lilly Oncology |
Barton Peterson |
54 | 2009 | Senior Vice President - Corporate Affairs and Communications |
David Ricks |
45 | 2012 | Senior Vice President, President - Lilly Bio-Medicines |
Jeffrey Simmons |
45 | 2008 | Senior Vice President and President - Elanco Animal Health |
Jacques Tapiero |
54 | 2010 | Senior Vice President and President - Emerging Markets |
Fionnuala Walsh |
53 | 2011 | Senior Vice President - Global Quality |
William Kaelin |
55 | 2012 | Director |
Ralph Alvarez |
57 | 2009 | Independent Director |
Katherine Baicker |
41 | 2011 | Independent Director |
Winfried Bischoff |
71 | 2000 | Independent Director |
Michael Eskew |
63 | 2008 | Independent Director |
J. Erik Fyrwald |
53 | 2005 | Independent Director |
Alfred Gilman |
71 | 1995 | Independent Director |
R. David Hoover |
67 | 2009 | Independent Director |
Karen Horn |
69 | 2012 | Independent Director |
Douglas Oberhelman |
60 | 2008 | Independent Director |
Franklyn Prendergast |
68 | 1995 | Independent Director |
Kathi Seifert |
63 | 1995 | Independent Director |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
